The study revealed that miR-422a inhibited TGF-β signaling and repressed SMAD4 mainly through cell experiments and bioinformatics analysis, alleviating muscle loss in male patients with COPD. Here, SMAD4 is linked to chronic obstructive pulmonary disease.